Developing a decision support tool for the continuation or deprescribing of antithrombotic therapy in patients receiving end-of-life care: Results of a European Delphi study.
Mahé I, Haviari S, Si Mohammed N, Højen AA, Font C, Konstantinides S, Kruip MJHA, Maiorana L, Szmit S, Abbel D, Bertoletti L, Edwards A, Edwards M, Gava A, Gussekloo J, Johnson MJ, Kumar R, Langendoen J, Lifford KJ, Mooijaart S, Pearson M, Portielje J, Seddon K, Trompet S, Helfer H, Klok FA, Noble S, Couffignal C; DELPHI Serenity Group.
Mahé I, et al. Among authors: hojen aa.
Thromb Res. 2026 Feb;258:109573. doi: 10.1016/j.thromres.2025.109573. Epub 2026 Jan 2.
Thromb Res. 2026.
PMID: 41548313